Acquiring Company
Perth-based suitor (unnamed)
Acquired Company
Mayne Pharma Group Limited
PerthBiotechnologyPharmaceuticalBiotechnologyHealth CarePharmaceuticalDescription
Mayne Pharma announced on Friday that it has found a buyer for its Australian section, including its Salisbury North drugs factory. A Perth-based suitor's $55.5 million bid was accepted by the board, which CEO Aaron Gray described as a defining step in the company's transformation. Mayne shares rose 13.65 per cent in one day and 21.26 per cent for the week.
Quick answer
Perth-based suitor (unnamed) is acquiring Mayne Pharma Group Limited, announced November 8, 2026. Perth-based suitor (unnamed) is based in Perth, Western Australia, Australia.
- How much did Perth-based suitor (unnamed) pay for Mayne Pharma Group Limited?
- The deal value was not disclosed.
- What does Perth-based suitor (unnamed) do?
- The buyer is a Perth-based company that has made a $55.5 million bid for the Australian section of Mayne Pharma, which was accepted by Mayne's board.
- Where are Perth-based suitor (unnamed) and Mayne Pharma Group Limited based?
- Perth-based suitor (unnamed) is based in Perth, Western Australia, Australia.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Indivior Pharmaceuticals Completes Acquisition of Supernus Pharmaceuticals (November 2, 2026)
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
- Nuformix proposes merger with Biovara (November 11, 2026)
- Charles River Laboratories to Acquire Bioanalysis and DMPK Operations from Frontage Holdings (November 9, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Evaris Pharma to buy Mayne's Australian arm (November 6, 2026)
Who to call at Perth-based suitor (unnamed), and when
When Perth-based suitor (unnamed) changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Perth-based suitor (unnamed) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Perth-based suitor (unnamed), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Perth-based suitor (unnamed). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Perth-based suitor (unnamed) makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Mayne Pharma Group Limited?
Mayne Pharma Group Limited was acquired by Perth-based suitor (unnamed), based in Perth. The deal was reported on November 9, 2026. The buyer is a Perth-based company that has made a $55.5 million bid for the Australian section of Mayne Pharma, which was accepted by Mayne's board. The text does not name the buyer. Perth-based suitor (unnamed) is privately held and operates in Biotechnology.
When did Perth-based suitor (unnamed) acquire Mayne Pharma Group Limited?
Perth-based suitor (unnamed)'s acquisition of Mayne Pharma Group Limited was reported on November 9, 2026. Mayne Pharma announced on Friday that it has found a buyer for its Australian section, including its Salisbury North drugs factory. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Mayne Pharma Group Limited do?
Mayne Pharma Group Limited is a pharmaceutical company based in Australia. It has a proven commercial expertise and is known for its strength in women's health and dermatology. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.